Used as an intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of anti-inflammatory and central nervous system agents. Its nitro-substituted aromatic structure combined with difluoroacetic functionality makes it valuable for constructing bioactive molecules where electron-withdrawing groups influence metabolic stability and binding affinity. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies, especially in optimizing lead compounds targeting enzyme inhibition. Also utilized in the preparation of novel fluorinated analogs in drug discovery programs seeking improved pharmacokinetic profiles.